| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea.
|
J Palliat Med
|
2007
|
1.25
|
|
2
|
Acute fibrinous and organizing pneumonia following hematopoietic stem cell transplantation.
|
Korean J Intern Med
|
2009
|
1.12
|
|
3
|
Attitudes of cancer patients, family caregivers, oncologists and members of the general public toward critical interventions at the end of life of terminally ill patients.
|
CMAJ
|
2011
|
1.05
|
|
4
|
A case of Wernicke's encephalopathy following fluorouracil-based chemotherapy.
|
J Korean Med Sci
|
2009
|
1.03
|
|
5
|
Complementary and alternative medicine in the undergraduate medical curriculum: a survey of Korean medical schools.
|
J Altern Complement Med
|
2012
|
1.00
|
|
6
|
Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
|
Tumori
|
2006
|
0.96
|
|
7
|
A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.
|
Oncology
|
2005
|
0.95
|
|
8
|
Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.
|
Acta Haematol
|
2007
|
0.93
|
|
9
|
The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives.
|
Support Care Cancer
|
2012
|
0.87
|
|
10
|
Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine.
|
Cancer Res Treat
|
2008
|
0.86
|
|
11
|
Expression of complement protein C5a in a murine mammary cancer model: tumor regression by interference with the cell cycle.
|
Cancer Immunol Immunother
|
2005
|
0.83
|
|
12
|
Cancer of unknown primary finally revealed to be a metastatic prostate cancer: a case report.
|
Cancer Res Treat
|
2009
|
0.81
|
|
13
|
Expression of cyclooxygenase-2 in human breast cancer: relationship with HER-2/neu and other clinicopathological prognostic factors.
|
Cancer Res Treat
|
2005
|
0.80
|
|
14
|
Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor.
|
Oncol Rep
|
2005
|
0.78
|
|
15
|
An evaluation of nutrition support for terminal cancer patients at teaching hospitals in Korea.
|
Cancer Res Treat
|
2006
|
0.78
|
|
16
|
Prognostic significance of CD44s expression in biliary tract cancers.
|
Ann Surg Oncol
|
2008
|
0.78
|
|
17
|
Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer.
|
Tumori
|
2014
|
0.77
|
|
18
|
The association of self-leadership, health behaviors, and posttraumatic growth with health-related quality of life in patients with cancer.
|
Psychooncology
|
2014
|
0.77
|
|
19
|
Efficacy of a training program for long-term disease- free cancer survivors as health partners: a randomized controlled trial in Korea.
|
Asian Pac J Cancer Prev
|
2013
|
0.77
|
|
20
|
Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.
|
Cancer Res Treat
|
2009
|
0.77
|
|
21
|
Gefitinib trial in a fanconi's anemia patient with multiple squamous cell carcinomas and hepatocellular carcinoma.
|
Cancer Res Treat
|
2005
|
0.75
|
|
22
|
Challenging problems in advanced malignancy: Case 1. Chylopericardium during the treatment of non-Hodgkin's lymphoma.
|
J Clin Oncol
|
2003
|
0.75
|
|
23
|
The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines.
|
Cancer Res Treat
|
2003
|
0.75
|
|
24
|
A Case of Primary Gastric Choriocarcinoma Presenting with Amenorrhea.
|
Cancer Res Treat
|
2002
|
0.75
|
|
25
|
[A case of type 2N von Willebrand disease with homozygous R816W mutation of the VWF gene in a Nepalese woman].
|
Korean J Lab Med
|
2008
|
0.75
|
|
26
|
Gemcitabine and Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Clinical Benefit Response-Oriented Phase II Study.
|
Cancer Res Treat
|
2003
|
0.75
|